Published in J Vasc Surg on June 11, 2010
Development and treatments of inflammatory cells and cytokines in spinal cord ischemia-reperfusion injury. Mediators Inflamm (2013) 0.97
Ultrafast and whole-body cooling with total liquid ventilation induces favorable neurological and cardiac outcomes after cardiac arrest in rabbits. Circulation (2011) 0.88
Facts and fiction: the impact of hypothermia on molecular mechanisms following major challenge. Mediators Inflamm (2012) 0.87
Prolonged Local Hypothermia Has No Long-Term Adverse Effect on the Spinal Cord. Ther Hypothermia Temp Manag (2015) 0.75
Reproducable paraplegia by thoracic aortic occlusion in a murine model of spinal cord ischemia-reperfusion. J Vis Exp (2014) 0.75
Spinal Cord Inflammation: Molecular Imaging after Thoracic Aortic Ischemia Reperfusion Injury. Radiology (2016) 0.75
Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol (2007) 4.13
Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol (2003) 3.87
Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation (2002) 3.67
Post-prenylation-processing enzymes as new targets in oncogenesis. Nat Rev Cancer (2005) 2.47
Involvement of a mitochondrial phosphatase in the regulation of ATP production and insulin secretion in pancreatic beta cells. Mol Cell (2005) 2.36
Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity. J Mol Biol (2004) 2.15
Overview of the Alliance for Cellular Signaling. Nature (2002) 2.15
Endovascular treatment of thoracic aortic aneurysms: results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis. J Vasc Surg (2005) 2.12
A risk prediction model for determining appropriateness of CEA in patients with asymptomatic carotid artery stenosis. Ann Surg (2013) 1.99
Progression of asymptomatic carotid stenosis despite optimal medical therapy. J Vasc Surg (2013) 1.97
beta-Catenin is a Nek2 substrate involved in centrosome separation. Genes Dev (2007) 1.96
Five-year results of endovascular treatment with the Gore TAG device compared with open repair of thoracic aortic aneurysms. J Vasc Surg (2008) 1.95
Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function. J Biol Chem (2005) 1.84
Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. J Clin Invest (2004) 1.81
Site-specific analysis of protein S-acylation by resin-assisted capture. J Lipid Res (2010) 1.77
Persistent type 2 endoleak after endovascular repair of abdominal aortic aneurysm is associated with adverse late outcomes. J Vasc Surg (2007) 1.76
Secondary intervention after endovascular abdominal aortic aneurysm repair. Ann Surg (2009) 1.73
Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease. J Vasc Surg (2009) 1.73
International controlled clinical trial of thoracic endovascular aneurysm repair with the Zenith TX2 endovascular graft: 1-year results. J Vasc Surg (2008) 1.67
Reaction path of protein farnesyltransferase at atomic resolution. Nature (2002) 1.63
Intermediate-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia. J Vasc Surg (2009) 1.60
A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells. Proc Natl Acad Sci U S A (2005) 1.59
Stent-graft versus open-surgical repair of the thoracic aorta: mid-term results. J Vasc Surg (2006) 1.56
Absence of the CAAX endoprotease Rce1: effects on cell growth and transformation. Mol Cell Biol (2002) 1.56
The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Proc Natl Acad Sci U S A (2006) 1.54
Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: a comparative experience. J Vasc Surg (2007) 1.49
Common femoral artery occlusive disease: contemporary results following surgical endarterectomy. J Vasc Surg (2008) 1.48
Balloon expandable stents facilitate right renal artery reconstruction during complex open aortic aneurysm repair. J Vasc Surg (2009) 1.48
Early outcomes of endovascular versus open abdominal aortic aneurysm repair in the National Surgical Quality Improvement Program-Private Sector (NSQIP-PS). J Vasc Surg (2005) 1.47
A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion. J Biol Chem (2006) 1.47
Surgical management of descending thoracic aortic disease: open and endovascular approaches: a scientific statement from the American Heart Association. Circulation (2010) 1.47
GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer. J Clin Invest (2007) 1.47
The Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg (2012) 1.46
Current results of open surgical repair of descending thoracic aortic aneurysms. J Vasc Surg (2006) 1.46
Late results of combined carotid and coronary surgery using actual versus actuarial methodology. Ann Thorac Surg (2005) 1.45
Thoracoabdominal aneurysm repair: a 20-year perspective. Ann Thorac Surg (2007) 1.44
Identification of a role for beta-catenin in the establishment of a bipolar mitotic spindle. J Biol Chem (2004) 1.43
Activation of Rap1 promotes prostate cancer metastasis. Cancer Res (2009) 1.41
Endovascular stenting of a penetrating axillary artery injury in a 14-year-old with 1-year follow-up. J Pediatr Surg (2009) 1.41
Contemporary management of carotid stenosis: carotid endarterectomy is here to stay. Perspect Vasc Surg Endovasc Ther (2007) 1.39
Biologic functions of the G12 subfamily of heterotrimeric g proteins: growth, migration, and metastasis. Biochemistry (2007) 1.39
Long-term outcomes after endovascular abdominal aortic aneurysm repair: the first decade. Ann Surg (2006) 1.38
A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Blood (2004) 1.37
A novel protein geranylgeranyltransferase-I inhibitor with high potency, selectivity, and cellular activity. J Biol Chem (2006) 1.35
A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells. J Biol Chem (2008) 1.32
Outcomes following endovascular abdominal aortic aneurysm repair (EVAR): an anatomic and device-specific analysis. J Vasc Surg (2008) 1.29
Structure of mammalian protein geranylgeranyltransferase type-I. EMBO J (2003) 1.28
Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. J Biol Chem (2005) 1.28
Androgen receptor activation by G(s) signaling in prostate cancer cells. J Biol Chem (2005) 1.26
Preoperative functional status predicts perioperative outcomes after infrainguinal bypass surgery. J Vasc Surg (2010) 1.25
Significant perioperative morbidity accompanies contemporary infrainguinal bypass surgery: an NSQIP report. J Vasc Surg (2009) 1.24
Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development. Cancer Cell (2005) 1.23
Targeting Ras signaling through inhibition of carboxyl methylation: an unexpected property of methotrexate. Proc Natl Acad Sci U S A (2003) 1.17
Pertussis-toxin-sensitive Galpha subunits selectively bind to C-terminal domain of neuronal GIRK channels: evidence for a heterotrimeric G-protein-channel complex. Mol Cell Neurosci (2005) 1.16
Management of diseases of the descending thoracic aorta in the endovascular era: a Medicare population study. Ann Surg (2010) 1.16
Long-term durability of open abdominal aortic aneurysm repair. J Vasc Surg (2007) 1.15
Galpha12 and Galpha13 negatively regulate the adhesive functions of cadherin. J Biol Chem (2002) 1.14
Outcomes after carotid endarterectomy: is there a high-risk population? A National Surgical Quality Improvement Program report. J Vasc Surg (2009) 1.14
Reassessment of parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism after 2 preoperative localization studies. Arch Surg (2006) 1.13
On the physiological importance of endoproteolysis of CAAX proteins: heart-specific RCE1 knockout mice develop a lethal cardiomyopathy. J Biol Chem (2003) 1.10
Aortic remodeling after endovascular repair of acute complicated type B aortic dissection. J Vasc Surg (2009) 1.08
Spinal cord complications after thoracic aortic surgery: long-term survival and functional status varies with deficit severity. J Vasc Surg (2008) 1.08
MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells. J Biol Chem (2013) 1.07
Endovascular management of patients with critical limb ischemia. J Vasc Surg (2011) 1.07
A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals. Hepatology (2013) 1.06
Role of G12 proteins in oncogenesis and metastasis. Br J Pharmacol (2009) 1.05
Incision and abdominal wall hernias in patients with aneurysm or occlusive aortic disease. J Vasc Surg (2003) 1.03
Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. J Immunol (2003) 1.03
Galphaz negatively regulates insulin secretion and glucose clearance. J Biol Chem (2007) 1.03
Selective uncoupling of G alpha 12 from Rho-mediated signaling. J Biol Chem (2005) 1.03
A novel model of acute murine hindlimb ischemia. Am J Physiol Heart Circ Physiol (2006) 1.03
Thoracoabdominal aneurysm repair: hybrid versus open repair. J Vasc Surg (2009) 1.02
Rho GTPase activity modulates Wnt3a/beta-catenin signaling. Cell Signal (2009) 1.01
A noninvasive murine model of hind limb ischemia-reperfusion injury. J Surg Res (2004) 1.01
Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg (2006) 1.01
Preoperative variables predict persistent type 2 endoleak after endovascular aneurysm repair. J Vasc Surg (2010) 1.01
Development of reproducible histologic injury severity scores: skeletal muscle reperfusion injury. Surgery (2007) 1.01
Kinetic studies of protein farnesyltransferase mutants establish active substrate conformation. Biochemistry (2003) 1.00
Prospective multicenter clinical trial (STABLE) on the endovascular treatment of complicated type B aortic dissection using a composite device design. J Vasc Surg (2011) 1.00
Optimal selection of patients for elective abdominal aortic aneurysm repair based on life expectancy. J Vasc Surg (2013) 0.99
Non-thermal, pulsed electric field cell ablation: A novel tool for regenerative medicine and scarless skin regeneration. Technology (Singap World Sci) (2013) 0.99
Contemporary management of descending thoracic and thoracoabdominal aortic aneurysms: endovascular versus open. Circulation (2008) 0.99
Analysis of the kinetic mechanism of recombinant human isoprenylcysteine carboxylmethyltransferase (Icmt). BMC Biochem (2004) 0.98
A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism. Hepatology (2005) 0.97
Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration. J Biol Chem (2009) 0.97
Determinants of carotid endarterectomy anatomic durability: effects of serum lipids and lipid-lowering drugs. J Vasc Surg (2005) 0.97